Wall Street analyst estimates for InfuSystem Holdings, Inc. (INFU): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services).
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 3 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| P/E Ratio | 29.96 |
| Price / Book | 4.29 |
| EV / EBITDA | 7.36 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $71.1M | $67.1M | $81.1M | $97.4M | $102.4M | $109.9M | $125.8M | $134.9M | $143.4M |
| Cost of Revenue | $25.8M | $27.7M | $28.1M | $34.2M | $38.6M | $43.8M | $49.4M | $62.7M | $64.5M | $63.1M |
| Gross Profit | $44.7M | $43.4M | $39.0M | $46.9M | $58.8M | $58.5M | $60.6M | $63.1M | $70.4M | $80.3M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $34.3M | $35.0M | $34.0M | $38.9M | $44.9M | $51.5M | $56.4M | $58.0M | $62.5M | $67.5M |
| Operating Expenses | $43.8M | $46.2M | $38.6M | $43.4M | $49.9M | $55.7M | $58.9M | $59.0M | $63.5M | $68.4M |
| Operating Income | $974000 | -$3.8M | $415000 | $3.5M | $8.8M | $2.8M | $1.7M | $4.1M | $6.9M | $11.9M |
| EBITDA | $11.7M | $8.6M | $11.7M | $15.8M | $22.8M | $17.3M | $14.9M | $16.5M | $20.0M | $25.2M |
| Interest Expense | $1.3M | $1.3M | $1.4M | $1.9M | $1.3M | $1.4M | $1.4M | $2.2M | $1.8M | $1.3M |
| Pre-tax Income | -$364000 | -$5.3M | -$1.0M | $1.5M | $7.5M | $1.3M | $130000 | $1.9M | $5.1M | $10.6M |
| Income Tax | -$142000 | $15.4M | $53000 | $163000 | -$9.8M | -$163000 | $112000 | $979000 | $2.7M | $4.0M |
| Net Income | -$222000 | -$20.7M | -$1.1M | $1.4M | $17.3M | $1.4M | $18000 | $872000 | $2.3M | $6.6M |
| EPS | $-0.01 | $-0.91 | $-0.05 | $0.07 | $0.86 | $0.07 | $0.00 | $0.04 | $0.11 | $0.32 |
| EPS (Diluted) | $-0.01 | $-0.91 | $-0.05 | $0.07 | $0.80 | $0.06 | $0.00 | $0.04 | $0.11 | $0.31 |
| Shares Outstanding (Diluted) | $22.6M | $22.7M | $21.4M | $20.8M | $21.7M | $22.0M | $21.5M | $21.6M | $21.7M | $21.1M |
Price
| Price | $12.45 |
| Market Cap | $251M |
| Exchange | AMEX |
| Country | US |
Related companies: ELMD · HSDT · IVA · KRMD · NNOX · NYXH · OBIO
Explore sector: Healthcare · Medical - Devices
More sections of INFU: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks